Menu

Proposed “Japanese NIH” Draws Fire

Scientific societies in Japan contend that a plan for an NIH-like agency to oversee the country’s science ministries will squash basic research.

Jun 25, 2013
Chris Palmer

Skyline of Tokyo’s Shinjuku commercial district. WIKIMEIDA, MORIO

Japanese scientists have expressed serious concerns about Prime Minister Shinzo Abe’s proposal to create a Japanese version of the National Institutes of Health that would coordinate research efforts across several ministries. Abe’s Growth Strategy—a plan for kick starting the country’s economic growth—includes an emphasis on expanding “the commercialization of innovative medical technologies.” The plan also calls for revising regulations to speed the approval of new drugs and medical devices, as well as changes to patent law and tax incentives to spur research commercialization.

A day before the draft plan was released last week, the heads of more than 50 life-science academic societies released a statement supporting the creation of an NIH-like funding agency to support biomedical research. However, the society chiefs also expressed concerns about Abe’s proposal. Their statement (in Japanese here) called for three provisions to the plan: the preservation of a bottom-up approach of promoting basic research; support for developing the next generation of researchers; and sufficient funding to foster true innovation.

At a press conference last week, Akira Amari, minister for economic revitalization, addressed concerns raised by the scientific community. “I would like to stress that we have no intention to try to tie down the people who are involved in very fundamental research,” he said.

Amari also said he has been approached by scientists who tell him that their work “is beginning to show some signs of eventually having some kind of possible commercial application,” but that they are not quite sure what steps to take to move in that direction. “We need to try to help these people,” he said, citing the possibility of collaborations between scientists in industry and academia. “It is very important to have someone in [a research] group who can look at the industrialization or commercialization aspects and provide some direction to the research,” he explained.

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Complete Pathology Solutions: Make Every Minute Count

Complete Pathology Solutions: Make Every Minute Count

From sample collection and handling, to fixation and processing, tissue staining, and covering all your IHC and water purification needs—you can have confidence in the quality of your results with MilliporeSigma's one-stop pathology solution.

Preparing Cell Or Tissue Lysates For ELISA Kits

Preparing Cell Or Tissue Lysates For ELISA Kits

RayBiotech manufactures over 2,000 high fully validated, GMP-compliant ELISA kits. In this blog post we explain how to prepare cell or tissue lysates for ELISA Kits.

Norgen Biotek Achieves Illumina Propel Certification as a Service Provider for Next Generation Sequencing

Norgen Biotek Achieves Illumina Propel Certification as a Service Provider for Next Generation Sequencing

Norgen Biotek Corp., an innovative privately held Canadian biotechnology company focusing primarily on nucleic acid and protein stabilization and purification, as well as providing high quality services to the scientific community, today announced that it has become Propel-Certified through Illumina as a Next Generation Sequencing (NGS) service provider.

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.